IBERSOL SGPS SA (IBS.LS) Stock Fundamental Analysis
ELI:IBS - Euronext Lisbon - PTIBS0AM0008 - Common Stock - Currency: EUR
Taking everything into account, IBS scores 4 out of 10 in our fundamental rating. IBS was compared to 58 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and the financial health of IBS get a neutral evaluation. Nothing too spectacular is happening here. IBS is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
IBS had positive earnings in the past year.
In the past year IBS had a positive cash flow from operations.
IBS had positive earnings in 4 of the past 5 years.
Each year in the past 5 years IBS had a positive operating cash flow.
1.2 Ratios
The Return On Assets of IBS (1.16%) is comparable to the rest of the industry.
IBS has a Return On Equity (2.54%) which is in line with its industry peers.
The Return On Invested Capital of IBS (3.13%) is comparable to the rest of the industry.
IBS had an Average Return On Invested Capital over the past 3 years of 3.32%. This is significantly below the industry average of 10.30%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.16% | ||
| ROE | 2.54% | ||
| ROIC | 3.13% |
ROA(3y)9.49%
ROA(5y)5.17%
ROE(3y)16.68%
ROE(5y)5.68%
ROIC(3y)3.32%
ROIC(5y)N/A
1.3 Margins
IBS has a Profit Margin (1.74%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of IBS has declined.
IBS has a Operating Margin (4.61%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of IBS has declined.
IBS has a Gross Margin of 49.59%. This is comparable to the rest of the industry: IBS outperforms 48.28% of its industry peers.
IBS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.61% | ||
| PM (TTM) | 1.74% | ||
| GM | 49.59% |
OM growth 3Y-40.02%
OM growth 5Y-6.76%
PM growth 3Y-42.54%
PM growth 5Y-4.22%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IBS is destroying value.
IBS has less shares outstanding than it did 1 year ago.
IBS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, IBS has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 1.95 indicates that IBS is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of IBS (1.95) is better than 62.07% of its industry peers.
IBS has a debt to FCF ratio of 6.53. This is a slightly negative value and a sign of low solvency as IBS would need 6.53 years to pay back of all of its debts.
IBS has a Debt to FCF ratio (6.53) which is in line with its industry peers.
IBS has a Debt/Equity ratio of 0.69. This is a neutral value indicating IBS is somewhat dependend on debt financing.
The Debt to Equity ratio of IBS (0.69) is better than 67.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 6.53 | ||
| Altman-Z | 1.95 |
ROIC/WACC0.51
WACC6.11%
2.3 Liquidity
A Current Ratio of 1.09 indicates that IBS should not have too much problems paying its short term obligations.
IBS has a better Current ratio (1.09) than 65.52% of its industry peers.
IBS has a Quick Ratio of 1.01. This is a normal value and indicates that IBS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.01, IBS is in the better half of the industry, outperforming 62.07% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.01 |
3. Growth
3.1 Past
IBS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -47.78%.
IBS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.23% yearly.
Looking at the last year, IBS shows a quite strong growth in Revenue. The Revenue has grown by 15.22% in the last year.
Measured over the past years, IBS shows a decrease in Revenue. The Revenue has been decreasing by -0.46% on average per year.
EPS 1Y (TTM)-47.78%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%-314.5%
Revenue 1Y (TTM)15.22%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%17.83%
3.2 Future
Based on estimates for the next years, IBS will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.06% on average per year.
IBS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.65% yearly.
EPS Next Y32.28%
EPS Next 2Y25.49%
EPS Next 3Y23.64%
EPS Next 5Y18.06%
Revenue Next Year15.39%
Revenue Next 2Y9.99%
Revenue Next 3Y8.52%
Revenue Next 5Y6.65%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 48.10, IBS can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of IBS is on the same level as its industry peers.
IBS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.87.
Based on the Price/Forward Earnings ratio of 19.05, the valuation of IBS can be described as rather expensive.
IBS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. IBS is cheaper than 68.97% of the companies in the same industry.
IBS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 35.34, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.1 | ||
| Fwd PE | 19.05 |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, IBS is valued cheaply inside the industry as 82.76% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.34 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
IBS's earnings are expected to grow with 23.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.49
PEG (5Y)N/A
EPS Next 2Y25.49%
EPS Next 3Y23.64%
5. Dividend
5.1 Amount
IBS has a Yearly Dividend Yield of 7.28%, which is a nice return.
IBS's Dividend Yield is rather good when compared to the industry average which is at 2.82. IBS pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, IBS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.28% |
5.2 History
The dividend of IBS is nicely growing with an annual growth rate of 48.65%!
Dividend Growth(5Y)48.65%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
242.99% of the earnings are spent on dividend by IBS. This is not a sustainable payout ratio.
IBS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP242.99%
EPS Next 2Y25.49%
EPS Next 3Y23.64%
ELI:IBS (8/15/2025, 7:00:00 PM)
9.62
0 (0%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners24.17%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap399.33M
Analysts83.33
Price Target11.82 (22.87%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.28% |
Yearly Dividend0.49
Dividend Growth(5Y)48.65%
DP242.99%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)11.84%
Min Revenue beat(2)11.28%
Max Revenue beat(2)12.41%
Revenue beat(4)4
Avg Revenue beat(4)8.54%
Min Revenue beat(4)0.18%
Max Revenue beat(4)12.41%
Revenue beat(8)7
Avg Revenue beat(8)6.47%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-11.21%
PT rev (3m)-2.76%
EPS NQ rev (1m)-100%
EPS NQ rev (3m)-100%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)14.04%
Revenue NQ rev (3m)14.04%
Revenue NY rev (1m)7.7%
Revenue NY rev (3m)7.7%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.1 | ||
| Fwd PE | 19.05 | ||
| P/S | 0.81 | ||
| P/FCF | 8.34 | ||
| P/OCF | 5.06 | ||
| P/B | 1.19 | ||
| P/tB | 1.68 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.2
EY2.08%
EPS(NY)0.51
Fwd EY5.25%
FCF(TTM)1.15
FCFY11.98%
OCF(TTM)1.9
OCFY19.75%
SpS11.85
BVpS8.12
TBVpS5.73
PEG (NY)1.49
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.16% | ||
| ROE | 2.54% | ||
| ROCE | 4.01% | ||
| ROIC | 3.13% | ||
| ROICexc | 4.09% | ||
| ROICexgc | 5.28% | ||
| OM | 4.61% | ||
| PM (TTM) | 1.74% | ||
| GM | 49.59% | ||
| FCFM | 9.73% |
ROA(3y)9.49%
ROA(5y)5.17%
ROE(3y)16.68%
ROE(5y)5.68%
ROIC(3y)3.32%
ROIC(5y)N/A
ROICexc(3y)5.24%
ROICexc(5y)N/A
ROICexgc(3y)7.05%
ROICexgc(5y)N/A
ROCE(3y)4.21%
ROCE(5y)N/A
ROICexcg growth 3Y-24.94%
ROICexcg growth 5Y-3.32%
ROICexc growth 3Y-22.88%
ROICexc growth 5Y-3.24%
OM growth 3Y-40.02%
OM growth 5Y-6.76%
PM growth 3Y-42.54%
PM growth 5Y-4.22%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
F-Score6
Asset Turnover0.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 6.53 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 6.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 560.26% | ||
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.01 | ||
| Altman-Z | 1.95 |
F-Score6
WACC6.11%
ROIC/WACC0.51
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)9.76%
Cap/Sales(5y)11.65%
Profit Quality(3y)200.89%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.78%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%-314.5%
EPS Next Y32.28%
EPS Next 2Y25.49%
EPS Next 3Y23.64%
EPS Next 5Y18.06%
Revenue 1Y (TTM)15.22%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%17.83%
Revenue Next Year15.39%
Revenue Next 2Y9.99%
Revenue Next 3Y8.52%
Revenue Next 5Y6.65%
EBIT growth 1Y0.48%
EBIT growth 3Y-20.54%
EBIT growth 5Y-7.19%
EBIT Next Year399.89%
EBIT Next 3Y91.9%
EBIT Next 5Y57.14%
FCF growth 1Y-27.17%
FCF growth 3Y-0.14%
FCF growth 5Y-9.32%
OCF growth 1Y-26.24%
OCF growth 3Y1.82%
OCF growth 5Y-6.35%